Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
On June 12, 2015, the U.S. Court of Appeals for the Federal Circuit, in Ariosa Diagnostics, Inc. v. Sequenom, Inc., slip opinion No. 2014-1139, 2014-1144 (Fed. Cir. June 12, 2015), affirmed a grant of summary judgment of invalidity of another patent in the biotech space. The patent at issue ' U.S. Patent No. 6,258,540, directed to methods of detecting and using cell-free fetal DNA in non-invasive prenatal diagnosis ' was deemed invalid for lack of patent-eligible subject matter. The decision adds to a long and growing list of patents that have fallen in the wake of the Supreme Court's recent 35 U.S.C. '101 jurisprudence. See, Mayo Collaborative Servs. v. Prometheus Laboratories, Inc., 566 U.S. ___, 132 S. Ct. 1289 (2012); Ass'n for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. ___, 133 S. Ct. 2107 (2013); Alice Corp. v. CLS Bank Int'l, 573 U.S. ___, 134 S. Ct. 2347 (2014); Bilski v. Kappos, 561 U.S. 593 (2010).
The Patent in Sequenom
The claims of the '540 patent at issue in Sequenom are directed to methods of amplifying and detecting the small fraction of paternally inherited cell-free fetal (cff) DNA from within the total amount of cffDNA circulating in the maternal bloodstream. Cell-free fetal DNA is difficult to differentiate from cell-free maternal DNA, but the inventors of the '540 Patent discovered that by focusing on specific sequences of paternal DNA that the mother is known to not share, cffDNA can be readily distinguished from cell-free maternal DNA. See, Appellants' Petition for Rehearing en Banc at 4, Ariosa, supra note 1. This was a significant discovery. Researchers had long utilized the cellular portion of maternal blood in prenatal diagnoses. However, maternal plasma and serum was never used for that purpose. It was routinely discarded as waste prior to the discovery of cffDNA in it and prior to the filing of the '540 Patent. See, Appellants' Petition at 3, supra note 3.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
Possession of real property is a matter of physical fact. Having the right or legal entitlement to possession is not "possession," possession is "the fact of having or holding property in one's power." That power means having physical dominion and control over the property.
In Rockwell v. Despart, the New York Supreme Court, Third Department, recently revisited a recurring question: When may a landowner seek judicial removal of a covenant restricting use of her land?